Trianni, Inc. Sustainability Profile
Trianni, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in the development of advanced antibody discovery technologies, particularly through its proprietary Trianni Mouse platform. Trianni's core offerings include high-quality monoclonal antibodies that are uniquely engineered for specificity and efficacy, catering to the needs of researchers in pharmaceuticals and diagnostics. The company has achieved notable milestones, including collaborations with major pharmaceutical firms, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to scientific excellence and innovation, Trianni, Inc. continues to drive advancements in therapeutic development and research applications.
DitchCarbon Score
How does Trianni, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Trianni, Inc.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Trianni, Inc.'s reported carbon emissions
Trianni, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of AbCellera Biologics Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Trianni, Inc., it is important to note that the company is part of a broader corporate family that may have its own sustainability initiatives. As such, any climate commitments or emissions data may be inherited from its parent organisation, AbCellera Biologics Inc., which could potentially have its own strategies for addressing carbon emissions. In the absence of specific emissions data or reduction initiatives, Trianni, Inc. is positioned within an industry context that increasingly prioritises sustainability and climate action. The company may benefit from aligning with industry standards and practices to enhance its environmental performance in the future.
How Carbon Intensive is Trianni, Inc.'s Industry?
How Carbon Intensive is Trianni, Inc.'s Location?
Trianni, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Trianni, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
